OPRX
MODD

Ellen O'Connor Vos

Known title: DirectorCIK: 0001534357

Ellen O'Connor Vos's purchase track record

Ellen O'Connor Vos has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/16/2022OPRX$8K+39.5%+10.1%
10/28/2021MODD$150Kpendingpending

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk. OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.

this person other insiders at OPRX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

Modular Medical (MODD) Featured in After-Market Movers. Modular Medical was highlighted in a recent list of healthcare stocks moving during Friday's after-market session. The stock is currently trading near its support level, with an RSI of 39.0. This technical position provides context for the recent price activity noted in the news.

this person other insiders at MODD

Transaction History

OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$8K
MODD▲ Buy$150K

We use analytics to understand how market-wall is used. No personal data is sold.